1776 Wealth
PLXP

1776 Wealth’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

1776 Wealth’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$3K – 326
2020
Q2 		$3K Hold
1,000
– – ﹤0.01% 314
2020
Q1 		$2K Hold
1,000
– – ﹤0.01% 308
2019
Q4 		$4K Buy
+1,000
New +$4.7K ﹤0.01% 310

Other funds holding PLXP

Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Heritage Way Advisors
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Cranbrook Wealth Management
Cranbrook Wealth Management Bloomfield Hills, Michigan $534M AUM 18.5% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

1776 Wealth's PLXP Position: Q3 2020 in Review

1776 Wealth sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2020, closing a stake of 1,000 shares — an estimated $3K sold.

1776 Wealth first reported a position in PLXP in Q4 2019 and held it in 3 quarters. The position peaked at $4K in Q4 2019. 15 funds tracked by Wall St. Rank hold PLXP as of Q3 2020.

  • 1776 Wealth reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • 1776 Wealth sold 1,000 PLx Pharma Inc. Common Stock shares in Q3 2020, an estimated $3K.
  • 1776 Wealth first reported a position in PLx Pharma Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • 1776 Wealth's PLx Pharma Inc. Common Stock position peaked at $4K in Q4 2019.
  • 15 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2020.

Based on 1776 Wealth's 13F filing for Q3 2020, filed 12 Nov 2020.